Arkolith/Insider Trading/CRNX/Form 4

Betz Stephen F.

Chief Scientific OfficerCrinetics Pharmaceuticals, Inc. (CRNX) · full profile →Form 4 · filed Jun 16, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.1M
Net Open-Market Flow
-$3.1M
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 12, 2025Option exercise(M)17K$9.28$154K197K
Jun 12, 2025Option exercise(M)72K$1.91$137K181K
Jun 12, 2025Sell(S)97K$32.23$3.1M100K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 12, 2025Option exercise(M)17K—$058K
Jun 12, 2025Option exercise(M)72K—$0109K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-086804) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML